Welireg
About Welireg
The active substance in Welireg is Belzutifan which is a chemically hypoxia-inducible-2 alpha (HIF-2α) inhibitor. The people who lack VHL protein have a very high level of HIF-2α which in turn can trigger the growth of VHL-associated tumors. The cellular side shows that HIF-2α moves to the cell nucleus and attaches to hypoxia-inducible 1 beta (HIF-1β) which activates tumor cell growth. Belzutifan blocks HIF-2α and inhibits pairing of HIF-2α and HIF-1β which leads to the shrinkage of VHL.
Strength: Belzutifan, 40 mg tablets
Recommended Dosage:
The recommended dosage of Belzutifan is 120 mg for oral use once daily until the disease progresses or reaches unacceptable toxicity.
- Welireg tablet can be taken with or without food at the same time of the day every day.
- Advise patients to swallow the whole tablet.
- Do not chew, crush, or split the Welireg tablet prior to swallowing.
- If a dose of Welireg is missed, it can be taken as soon as possible on the same day and the regular daily dose should be resumed the next day.
- Discontinue if vomiting occurs anytime and take the next dose on the next day.
Warnings & Precautions:
- Welireg can cause severe anemia that can require blood transfusion.
- Welireg can cause severe hypoxia that may require discontinuation, supplemental oxygen, or hospitalization.
- Welireg can cause fetal harm when administered to a pregnant woman.
Common Welireg Side Effects
- Decreased hemoglobin
- Anemia
- Fatigue
- Increased creatinine
- Headache
- Dizziness
- Increased glucose
- Nausea
Use in Specific Population
- Lactation: breastfeeding is not advised.
- Infertility: It can impair the fertility of both males and females.
Storage and Handling
- The formulation is debossed with “177” on one side and plain on the other side, available in bottles of 90 tablets with a child-resistant closure.
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
For the medicine procurement, we follow a simple four-step process.
- Enquiry about the medicine: When you request information about the medication you require, we will handle your data. Our Named Access Program Support team will contact you within 24 hours to assist.
- Verification Process: In our mission to help patients access medications that may not be approved or readily accessible in their home countries, Sansfro ensures the verification of medicine availability and approval. Additionally, we thoroughly review the patient’s prescription and medical information for accuracy and compliance.
- Sourcing the Medicine: Upon successfully completing the verification process, our team will initiate contact with our network of suppliers to source the required medication for you. Subsequently, our team works diligently to obtain the most favorable quotes for your medicines and oversees the processing of your order.
- Safe Delivery: We will coordinate the secure delivery of your consignment upon approval of the final quote. Our team of logistics specialists is available to provide consignment tracking assistance. Acknowledging that the Named Access Program industry is susceptible to unauthorized channels is essential. To uphold the safe and legal provision of medications, we rigorously adhere to Standard Operating Procedures.
For the importation of medication, we will require the following documents from the patient:
- An authentic prescription copy.
- A proof of identity document.
- Information about the healthcare provider in charge.
- A current residential address.
Once all these documents are provided, the Sansfro team will begin the import license application process. This license is a crucial requirement to facilitate the procurement of the necessary medication upon receiving government approval.
No news found.
About Sansfro
Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.
Know More...FAQ'S
What are the active ingredients in Welireg?
The active ingredient in Welireg is Belzutifan
What are the possible side effects of Welireg?
Welireg may cause side effects, including:
- feeling tired
- increased creatinine (kidney function test)
- headache
- feeling dizzy
- increased blood sugar (glucose) levels
- nausea
What is Welireg cost in India?
For pricing related queries kindly reach out to our Patient Support Team at (+91) 9315705373 or help@sansfro.com
What is Welireg price outside India?
For enquiry related to Oxlumo price kindly reach out to our Patient Support Team at (+91) 9315705373 or help@sansfro.com
How Welireg should be stored?
Store Welireg at room temperature between 68°F to 77°F (20°C to 25°C). The Welireg bottle contains 2 desiccant canisters that help keep your medicine dry. Do not eat the desiccant canisters.
Dr Anchal Aryan
Medical counselor
Patient Stories
Word Wide Delivery:
India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.
